Reimmunization after bone marrow transplantation - Current recommendations and perspectives

23Citations
Citations of this article
39Readers
Mendeley users who have this article in their library.

Abstract

Autologous and allogeneic bone marrow transplantation (BMT) recipients lose immune memory of exposure to infectious agents and vaccines accumulated through a lifetime and therefore need to be revaccinated. Diphtheria toxoid, tetanus toxoid, pertussis vaccine (children <7 years old), Haemophilus influenzae type b conjugate, 23-valent pneumococcal polysaccharide, inactivated influenza vaccine, inactivated polio vaccine and live-attenuated measles-mumps-rubella vaccine are the currently recommended vaccines to be included in a vaccination program after BMT. For most of them, the best time to vaccinate, the number of vaccine doses and/or the duration of immunity after vaccination have not been established. Vaccination protocols vary greatly among BMT centers, suggesting that the lack of sufficient data has not permitted the formulation of reliable recommendations. The use of other vaccines and the perspectives for different vaccination protocols are analyzed in this review.

Cite

CITATION STYLE

APA

Machado, C. M. (2004). Reimmunization after bone marrow transplantation - Current recommendations and perspectives. Brazilian Journal of Medical and Biological Research. Associacao Brasileira de Divulgacao Cientifica. https://doi.org/10.1590/S0100-879X2004000100021

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free